Conmed (CNMD) Tops Q3 EPS by 65c
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $46.93 --0%
EPS Growth %: -7.4%
Financial Fact:
Gross profit: 101.21M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -7.4%
Financial Fact:
Gross profit: 101.21M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Conmed (NASDAQ: CNMD) reported Q3 EPS of $0.88, $0.65 better than the analyst estimate of $0.23. Revenue for the quarter came in at $237.8 million versus the consensus estimate of $205.92 million.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler lists 5 chip stocks to buy
- UBS Reiterates Buy Rating on HF Sinclair (DINO) on Strong Guidance
- Oppenheimer Starts Aehr Test Systems (AEHR) at Outperform, 'AI Burn-In Inflection Underappreciated'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
